Blood flow guides sequential support of neutrophil arrest and diapedesis by PILR-β1 and PILR-α

9 figures, 3 videos, 4 tables and 1 additional file

Figures

Figure 1 with 2 supplements
Characterization of PILR-α-/- and PILR-β1-/-neutrophils for surface expression of molecules involved in extravasation.

Ly6G+ bone marrow neutrophils from WT, PILR-α-/- or PILRβ1-/- mice were analyzed for indicated antigens by FACS. Representative histograms of at least three independent experiments are shown in (A) …

https://doi.org/10.7554/eLife.47642.002
Figure 1—figure supplement 1
Quantification of PILR subtypes neutrophils.

(A) Ly6G+ WT and PILR-α-/- bone marrow cells were stained with a primary antibody recognizing both PILR-α and PILR-β in the absence (black) or presence of 2.5-fold (red) or 5-fold (orange) excess of …

https://doi.org/10.7554/eLife.47642.003
Figure 1—figure supplement 2
Characterization of immune subsets in PILR-α-/- and PILR-β1-/-mice.

WT (black), PILR-α-/- (red) and PILR-b1-/- (blue) CD45+ leukocytes from spleen (A), bone marrow (B) or peripheral blood (C) were stained by antibodies against the indicated antigens and analyzed by …

https://doi.org/10.7554/eLife.47642.005
Impact of PILRs on neutrophil extravasation in the inflamed cremaster.

WT, PILR-α-/- and PILR-β1-/- mice were stimulated with intrascrotal TNF-α for 2 hr. Cremaster muscles were exposed and examined for neutrophil extravasation by intravital microscopy (IVM) for (A) …

https://doi.org/10.7554/eLife.47642.012
Figure 3 with 1 supplement
PILR-β1 is required for CD99-stimulated neutrophil adhesion on ICAM-1-Fc in vitro.

Flow chamber surfaces were coated with P-selectin-Fc, ICAM-1-Fc and CXCL-1, and co-coated with either CD99-Fc or human IgG1 control (hIgG). PILR-α-/- (A) or PILR-β1-/- (B) PMN were mixed with …

https://doi.org/10.7554/eLife.47642.020
Figure 3—figure supplement 1
PILRs modulate β2 integrin activity via Syk.

(A) PMN were pre-treated with non-crosslinking rabbit IgG or crosslinking polyclonal anti-PILRs for 15 min, and then stimulated with 100 ng/ml CXCL-1 for 0 s (unstimulated), 30 s, 60 s and 75 s, …

https://doi.org/10.7554/eLife.47642.021
PILR-β1, but not PILR-α, is essential for CD99-stimulated support of neutrophil adhesion in vivo.

WT or CD99-/- mice received bone marrow transplantation from WT (A–F) or PILR-α-/- (A–C) or PILR-β1-/- (D–F). IVM measurement of (A, D) rolling flux fraction, (B, E) adhesion and (C, F) …

https://doi.org/10.7554/eLife.47642.031
Figure 5 with 2 supplements
Shear stress enhances the interaction of CD99 with PILR-β.

(A) CHO cells overexpressing CD99 (CHO-CD99) were constructed and analyzed for surface expression of CD99. Solid tracks, anti-CD99; dotted tracks, secondary antibody only. (B) 1:1 Cell mixtures of …

https://doi.org/10.7554/eLife.47642.038
Figure 5—figure supplement 1
CD99-specific interaction with coated PILR-Fc under constant flow.

Parental CHO cells (CHO-WT) or CHO cells expressing full-length CD99 (CHO-CD99FL) were passed over a surface coated with PILR-α-Fc (blue) or PILR-β-Fc (red), or over an uncoated control surface at a …

https://doi.org/10.7554/eLife.47642.039
Figure 5—figure supplement 2
CD99-Fc and full-length CD99 produced in CHO cells are glycosylated.

(A) CD99-Fc was treated with 0 or 0.3 U/ml sialidase at 37°C for 1 hr and analyzed by Western blot. (B) CHO-CD99 was similarly treated with sialidase. Lysate was prepared and analyzed by Western blot.

https://doi.org/10.7554/eLife.47642.041
Shear switches on PILR-β1-stimulated adhesion of neutrophils to endothelial monolayers under flow.

(A) PMN from WT or PILR-β1-/- mice were allowed to adhere onto TNF-α inflamed and CXCL-1 pretreated MDMVEC under stasis. Adherent cells were counted. n = 17 fields per genotype from two experiments. …

https://doi.org/10.7554/eLife.47642.047
Figure 7 with 3 supplements
PILR-α supports crawling and diapedesis.

(A) Correlation between adhesion and transmigration of WT, PILR-α-/- and PILR-β1-/- PMNs in static transendothelial cell migration (TEM) assays through MDMVEC. n = 96 (WT), 54 (PILR-α-/-) and 41 …

https://doi.org/10.7554/eLife.47642.052
Figure 7—figure supplement 1
PILR-α suppresses adhesion on endothelial monolayers.

(A) WT or PILR-α-/- PMNs were allowed to adhere onto TNF-α stimulated MDMVEC and adherent cells were counted. n = 16 fields from two experiments. (B) WT or PILR-α-/- PMNs were allowed to adhere on …

https://doi.org/10.7554/eLife.47642.053
Figure 7—figure supplement 2
Effect of PILR-α on leukocyte crawling requires endothelial surface.

Transmigration of WT and PILR-α- /- PMNs towards 40 ng/ml CXCL-1 through polycarbonate transwell filters (3 µm pore size) coated with 2 µg/ml ICAM-1-Fc for 1 hr at 37°C. n = 6 transwells. Groups …

https://doi.org/10.7554/eLife.47642.057
Figure 7—figure supplement 3
PILR-α on cellular surface is unavailable for CD99-Fc binding due to blockade by cis-interaction with sialylated entities.

CHO- WT (black) or overexpressing PILR-α (CHO-PILR-α, blue) were treated with 0 or 0.3 U/ml sialidase at 37°C for 30 min. Cells were washed and probed for CD99-Fc binding. CD99-Fc binding on cell …

https://doi.org/10.7554/eLife.47642.056
Graphical depiction.

An antagonistic pair of receptors, PILR-β1 and PILR-α, supports neutrophil arrest and seamless transition to crawling via modulating β2 integrin activity at different steps during extravasation.

https://doi.org/10.7554/eLife.47642.062
Author response image 1
Transmigration of WT and PILR-α-/- PMNs towards 40ng/ml CXCL1 through polycarbonate transwell filters (3μm pore size) coated with 2μg/ml ICAM-1-Fc for 1 h at 37°C.

(P value is 0.0658 (2-tailed t-test)).

https://doi.org/10.7554/eLife.47642.065

Videos

Video 1
Representative IVM video of a vessel in WT in Figure 2.
https://doi.org/10.7554/eLife.47642.017
Video 2
Representative IVM video of a vessel in PILR-α-/- in Figure 2.
https://doi.org/10.7554/eLife.47642.018
Video 3
Representative IVM video of a vessel in PILR-β1-/- in Figure 2.
https://doi.org/10.7554/eLife.47642.019

Tables

Table 1
Hemodynamic parameters of mice in full knockout characterization in Figure 2.

Genotypes, number of mice, number of venules, venule diameters, leukocyte counts, blood velocities and Newtonian wall shear stresses are shown as mean ± SEM.

https://doi.org/10.7554/eLife.47642.016
GenotypeMiceVenulesDiameter (μm)Leukocyte counts (106 cells/ml)Mean blood velocity (mm/s)Newtonian wall shear rate (s−1)
WT84028.7 ± 0.74.34 ± 0.621.22 ± 0.02350 ± 9
PILRα-/-73729.4 ± 0.85.19 ± 0.461.23 ± 0.02343 ± 9
PILRβ1-/-73528.2 ± 0.83.95 ± 0.451.23 ± 0.02357 ± 10
Table 2
Hemodynamic parameters of bone marrow transplanted chimeric mice for intravital microscopy in Figure 4A–C.

Genotypes of donors and recipients, number of mice, number of venules, venule diameters, leukocyte counts, blood velocities and Newtonian wall shear stresses are shown as mean ± SEM.

https://doi.org/10.7554/eLife.47642.036
Donor genotype (neutrophil)Recipient genotype (endothelium)MiceVenulesDiameter (μm)Leukocyte counts (106 cells/ml)Mean blood velocity (mm/s)Newtonian wall shear rate (s−1)
WTWT53925.4 ± 0.63.27 ± 0.191.21 ± 0.00388 ± 8
WTCD99-/-53824.2 ± 0.53.52 ± 0.071.20 ± 0.01404 ± 8
PILRα-/-WT53924.5 ± 0.62.87 ± 0.111.20 ± 0.01403 ± 9
PILRα-/-CD99-/-43423.8 ± 0.63.47 ± 0.121.21 ± 0.01413 ± 10
Table 3
Hemodynamic parameters of bone marrow transplanted chimera mice for intravital microscopy in Figure 4D–F.

Genotypes of donors and recipients, number of mice, number of venules, venule diameters, leukocyte counts, blood velocities and Newtonian wall shear stresses are shown as mean ± SEM.

https://doi.org/10.7554/eLife.47642.037
Donor genotype (neutrophil)Recipient genotype (endothelium)MiceVenulesDiameter (μm)Leukocyte counts (106 cells/ml)Mean blood velocity (mm/s)Newtonian wall shear rate (s−1)
WTWT42323.3 ± 0.73.13 ± 0.301.24 ± 0.01431 ± 10
WTCD99-/-52723.4 ± 0.85.46 ± 0.381.24 ± 0.01434 ± 12
PILRβ1-/-WT52924.0 ± 0.74.56 ± 0.881.23 ± 0.01416 ± 10
PILRβ1-/-CD99-/-53622.6 ± 0.55.58 ± 0.371.25 ± 0.01443 ± 9
Key resources table
Reagent type
(species) or resource
DesignationSource or referenceIdentifiersAdditional information
Genetic reagent (M. musculus)CD99-/-PMID: 28223280
Genetic reagent (M. musculus)PILR-α-/-This paper
Genetic reagent (M. musculus)PILR-β1-/-This paper
Cell line (C. griseus)CHO-CD99PMID: 15280198
AntibodyRabbit anti-PILR-α C-terminus (VD67, polyclonal)This paperFC: 5 μg/ml
AntibodyRabbit anti-PILRs (VD65, crossreactive, polyclonal)This paperFC: 2 μg/ml
Functional assay: 20 μg/ml
AntibodyRat anti-F4/80-FITC (BM8)BiolegendCat# 123107FC: 1:100
AntibodyRat anti-LFA-1-PE (H155-78)BiolegendCat# 141005FC: 1:100
AntibodyRat anti-Ly6G-(APC or FITC) (1A8)BiolegendCat# 127613
Cat# 127605
FC: 1:250
AntibodyRat anti-CD11b-PE (M1/70)BiolegendCat# 101207FC: 1:100
AntibodyArmenian Hamster anti- CD11c-PE (N418)BiolegendCat# 117307FC: 1:100
AntibodyRat anti-CD45-APC (30F11)BiolegendCat# 103111FC: 1:100
AntibodyRat anti-CD182-FITC (SA045E1)BiolegendCat# 149607FC: 1:100
AntibodyMouse anti-NK1.1-PE (PK136)BiolegendCat# 108707FC: 1:100
AntibodyRat anti-B220-PE (RA3-6B2)BD BiosciencesCat# 93992FC: 1:100
AntibodyRat anti-CD4-PE (RM4-5)BD BiosciencesCat# 26589FC: 1:100
AntibodyRat anti-CD162-PE (2PH1)BD PharmingenCat# 555306FC: 1:100
AntibodyRat anti-CD8-FITC (53–6.7)eBioscienceCat# 11-0081-85FC: 1:100
AntibodyRabbit anti-Syk (polyclonal)Thermo FisherCat# PA5-27262IP: 3 μg/ 5×106 PMN
WB: 1:1000
AntibodyMouse anti-phosphotyrosine (4G10)Merck MilliporeCat# 05–321WB: 1 μg/ml
Peptide, recombinant proteinCD99-FcPMID: 15280198
Peptide, recombinant proteinP-sel-FcPMID: 28223280
Peptide, recombinant proteinICAM-1-FcPMID: 28223280
Peptide, recombinant proteinTNF-αPeproTechCat# 315-01A
Commercial assay or kitGeneArt Precision gRNA Synthesis KitThermo FisherA29377
Software, algorithmFlowJo v10FlowJo, LLC
Software, algorithmCytExpertBeckman Coulterv2.3.0.84
FACS data acquisition
Software, algorithmZeiss ZEN (blue edition)ZeissImage/video acquisition
Software, algorithmFiji Image JPMID: 27713081Plugin: Trackmate

Additional files

Download links